Clinical Trial: A Study to Evaluate How the Body Processes 14C-VX-993 After a Single Oral Dose

U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06886269) titled 'A Study to Evaluate How the Body Processes 14C-VX-993 After a Single Oral Dose' on March 14.

Brief Summary: The purpose of the study is to evaluate the routes and rate of elimination and recovery of total radioactivity (TRA) and characterize the Pharmacokinetic (PK) of VX-993 after a single oral dose of 14C-VX-993

Study Start Date: March 21

Study Type: INTERVENTIONAL

Condition: Pain

Intervention: DRUG: 14C-VX-993

Solution for Oral Administration.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Vertex Pharmaceuticals Incorporated

Published by HT Digital Content Services with permission from Health Daily Digest....